15-12B: Notice of termination of registration of a class of securities under Section 12(b)
Published on March 14, 2011
|
|
|
|
|
|
|
UNITED STATES |
|
||
|
|
SECURITIES AND EXCHANGE COMMISSION |
|
|
|
|
|
Washington, D.C. 20549 |
|
|
|
|
|
|
|
|
|
|
|
FORM 15 |
|
||
|
|
|
|
|
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number : 001-13467
Commonwealth Biotechnologies, Inc
(Exact name of registrant as specified in its charter)
718 Grove Road, Midlothian, VA 23114
(Address, including zip code, and telephone number, including area code,
of registrants principal executive office)
Common Stock, no par value per share
(Title of each class of securities covered by this form)
None
(Title of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
|
|
Rule 12g-4(a)(1) |
|
|
|
Rule 12g-4(a)(2 |
o |
|
|
Rule 12h-3( b)(1)(i) |
o |
|
|
Rule 12h-3(b)(1)(ii) |
o |
|
|
Rule 15d-6 |
xo |
Approximate number of holders of record as of the certification or notice date: 1200
Pursuant to the requirements of the Securities Exchange Act of 1934, Commonwealth Biotechnologies, Inc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
Date: March 14, 2011 |
Commonwealth Biotechnologies, Inc |
|
|
|
|
|
|
|
By: |
/s/ Bill Guo |
|
|
|
Bill Guo, Chaiman |
|
|
|